OverviewSuggest Edit

Phibro Animal Health is an animal health and mineral nutrition company. It operates through three segments: Animal Health, Mineral Nutrition and Performance Products. The Company develops, manufactures, and markets animal health products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. It also provides products for the prevention of different diseases. 

TypePublic
Founded2003
HQTeaneck, US
Websitepahc.com
Employee Ratings3.9

Latest Updates

Employees (est.) (Jun 2019)1,600(+7%)
Job Openings4
Revenue (FY, 2020)$800.4 M(-3%)
Share Price (Sept 2020)$18.5 (+2%)
Cybersecurity ratingAMore

Key People/Management at Phibro Animal Health

Jack C. Bendheim

Jack C. Bendheim

Chairman of the Board of Directors, President and Chief Executive Officer
Daniel M. Bendheim

Daniel M. Bendheim

Director and Executive Vice President, Corporate Strategy
Larry L. Miller

Larry L. Miller

COO
Gerald K. Carlson

Gerald K. Carlson

Director
Richard G. Johnson

Richard G. Johnson

CFO
Sam Gejdenson

Sam Gejdenson

Director
Show more

Phibro Animal Health Office Locations

Phibro Animal Health has an office in Teaneck
Teaneck, US (HQ)
300 Frank W Burr Blvd #21
Show all (1)

Phibro Animal Health Financials and Metrics

Phibro Animal Health Revenue

Embed Graph
View revenue for all periods
Phibro Animal Health's revenue was reported to be $800.35 m in FY, 2020
USD

Revenue (FY, 2020)

800.4m

Gross profit (FY, 2020)

256.9m

Gross profit margin (FY, 2020), %

32.1%

Net income (FY, 2020)

33.6m

EBIT (FY, 2020)

69.2m

Market capitalization (15-Sept-2020)

772.6m

Closing stock price (15-Sept-2020)

18.5

Cash (30-Jun-2020)

36.3m

EV

1.1b
Phibro Animal Health's current market capitalization is $772.6 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

11.8m29.2m33.6m56.1m29.2m57.6m36.3m

Accounts Receivable

113.9m111.1m123.8m125.8m135.7m159.0m126.5m

Prepaid Expenses

20.5m22.4m27.2m

Inventories

30.4m23.6m5.2m161.2m178.2m198.3m196.7m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(3.1m)60.3m82.7m64.6m64.9m54.7m33.6m

Depreciation and Amortization

21.5m21.6m23.5m26.0m26.9m27.6m32.3m

Inventories

(31.0k)7.4m(6.9m)5.4m(24.3m)(21.0m)(12.9m)

Accounts Payable

1.7m4.8m(3.2m)(3.1m)2.4m12.1m(7.7m)
USDQ3, 2014

Debt/Equity

-3.8 x

Debt/Assets

0.6 x

Financial Leverage

-6 x
Show all financial metrics

Phibro Animal Health Operating Metrics

Phibro Animal Health's Customers was reported to be 3 k in FY, 2016.
FY, 2015FY, 2016

Customers

2.90 k3 k
Show all operating metrics

Phibro Animal Health Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Phibro Animal Health Online and Social Media Presence

Embed Graph

Phibro Animal Health News and Updates

Phibro Animal Health Corporation Announces a Significant Advance in the Development of a Vaccine Against African Swine Fever

TEANECK, N.J., July 08, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced it is pursuing patent protection following a significant advance in the on-going development of a vaccine for African Swine Fever (ASF).  This important step in the vaccine development p…

Phibro Animal Health Corporation Reports Third Quarter Results

TEANECK, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its third quarter ended March 31, 2019.

Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2019 Healthcare Conference

TEANECK, N.J., April 16, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the Bank of America Merrill Lynch 2019 Healthcare Conference being held at the Encore Wynn, Las Vegas, Nevada.

Phibro Animal Health Corporation Reports Second Quarter Results

TEANECK, N.J., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its second quarter ended December 31, 2018.

Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2019 Animal Health Summit

TEANECK, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) Chairman, President and Chief Executive Officer Jack Bendheim, Chief Financial Officer Richard Johnson and Executive Vice President, Corporate Strategy Daniel Bendheim will address financial analysts an…

Farm Animal Drugs Market Global Demand, Growth Analysis & Opportunity Outlook 2023: top key players like Bayer AG, Boehringer Ingelheim GmbH, Zoetis, Sequent Scientific, Phibro Animal Health Corporation

This positive growth over these years can be attributed to a rapid rise in the demand for quality pharmaceuticals and food security that fuel the increased adoption of farm animal drugs. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

Phibro Animal Health Frequently Asked Questions

  • When was Phibro Animal Health founded?

    Phibro Animal Health was founded in 2003.

  • Who are Phibro Animal Health key executives?

    Phibro Animal Health's key executives are Jack C. Bendheim, Daniel M. Bendheim and Larry L. Miller.

  • How many employees does Phibro Animal Health have?

    Phibro Animal Health has 1,600 employees.

  • What is Phibro Animal Health revenue?

    Latest Phibro Animal Health annual revenue is $800.4 m.

  • What is Phibro Animal Health revenue per employee?

    Latest Phibro Animal Health revenue per employee is $500.2 k.

  • Who are Phibro Animal Health competitors?

    Competitors of Phibro Animal Health include Dirt-to-Dinner, Sresta and Revere.

  • Where is Phibro Animal Health headquarters?

    Phibro Animal Health headquarters is located at 300 Frank W Burr Blvd #21, Teaneck.

  • Where are Phibro Animal Health offices?

    Phibro Animal Health has an office in Teaneck.

  • How many offices does Phibro Animal Health have?

    Phibro Animal Health has 1 office.